DOXUVIA Trademark

Trademark Overview

On Wednesday, February 19, 2020, a trademark application was filed for DOXUVIA with the United States Patent and Trademark Office. The USPTO has given the DOXUVIA trademark a serial number of 88802340. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by DUCHESNAY INC.. The DOXUVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of nausea
doxuvia

General Information

Serial Number88802340
Word MarkDOXUVIA
Filing DateWednesday, February 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of nausea

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDUCHESNAY INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBlainville, Quebec J7C5E2
CA
Party NameDUCHESNAY INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBlainville, Quebec J7C5E2
CA

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2022SOU EXTENSION 4 GRANTED
Monday, July 18, 2022SOU EXTENSION 4 FILED
Monday, July 18, 2022TEAS EXTENSION RECEIVED
Wednesday, February 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 31, 2022SOU EXTENSION 3 GRANTED
Monday, January 31, 2022SOU EXTENSION 3 FILED
Monday, January 31, 2022TEAS EXTENSION RECEIVED
Thursday, July 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 20, 2021SOU EXTENSION 2 GRANTED
Tuesday, July 20, 2021SOU EXTENSION 2 FILED
Tuesday, July 20, 2021TEAS EXTENSION RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020SOU EXTENSION 1 GRANTED
Wednesday, November 11, 2020SOU EXTENSION 1 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 8, 2020ASSIGNED TO EXAMINER
Monday, February 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 22, 2020NEW APPLICATION ENTERED

Related Keywords

doxuvia nausea treatment preparations pharmaceutical